Halbert Hargrove Global Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$77K	Hold	1,093	–	–	﹤0.01%	164
2026 Q2	$62.1K	Hold	1,093	–	–	﹤0.01%	200
2026 Q1	$47.8K	Hold	1,093	–	–	﹤0.01%	195
2025 Q4	$49.7K	Sell	1,093 -2,326	-68%	-$103K	﹤0.01%	189
2025 Q3	$133K	Sell	3,419 -2	-0.1%	-$72	0.01%	124
2025 Q2	$115K	Buy	3,421 +2,209	+182%	+$69.9K	0.01%	108
2025 Q1	$38.5K	Sell	1,212 -886	-42%	-$33.6K	﹤0.01%	162
2024 Q4	$81.5K	Sell	2,098 -1,042	-33%	-$43.8K	﹤0.01%	120
2024 Q3	$141K	Sell	3,140 -55	-2%	-$2.46K	0.01%	90
2024 Q2	$133K	Sell	3,195 -75	-2%	-$3.14K	0.01%	91
2024 Q1	$149K	Buy	+3,270	New	+$149K	0.01%	99
2023 Q4	–	Sell	-3,365	Closed	-$137K	–	100
2023 Q3	$137K	Buy	3,365 +225	+7%	+$10.2K	0.01%	96
2023 Q2	$152K	Buy	3,140 +1	+0%	+$50	0.01%	92
2023 Q1	$155K	Buy	3,139 +93	+3%	+$4.79K	0.01%	164
2022 Q4	$154K	Sell	3,046 -431	-12%	-$22.2K	0.01%	161
2022 Q3	$175K	Buy	+3,477	New	+$196K	0.01%	150

Other funds holding GNOM

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $17.7B AUM 20.22% 1-Year Est. Return

Polaris Financial Partners Westerville, Ohio $223M AUM

Stratos Wealth Partners Beachwood, Ohio $9.8B AUM 20.15% 1-Year Est. Return

Creative Financial Designs Kokomo, Indiana $2.22B AUM 15.38% 1-Year Est. Return

Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.49B AUM 21.31% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Halbert Hargrove Global Advisors's GNOM Position: Q3 2026 in Review

Halbert Hargrove Global Advisors held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q3 2026 at 1,093 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

Halbert Hargrove Global Advisors first reported a position in GNOM in Q3 2022 and has held it in 16 quarters since. The position peaked at $175K in Q3 2022. 44 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

Halbert Hargrove Global Advisors held 1,093 shares of Global X Genomics & Biotechnology ETF worth $77K as of Q3 2026.
Halbert Hargrove Global Advisors left its Global X Genomics & Biotechnology ETF share count unchanged in Q3 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q3 2026, its #164 holding.
Halbert Hargrove Global Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2022 and has held it in 16 quarters since.
Halbert Hargrove Global Advisors's Global X Genomics & Biotechnology ETF position peaked at $175K in Q3 2022.
44 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.